Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Jul 22, 2026
Nebius Group (NBIS) Stock Drops -24% in 30 Days Amid Neocloud Sector Selloff

Nebius Group (NBIS) Stock Drops -24% in 30 Days Amid Neocloud Sector Selloff

Key Takeaways

  • Nebius Group shares fell approximately 24% over the last 30 days, declining from $283.61 on June 22 to $216.92 on July 21, despite a sharp single-day bounce after Nvidia disclosed a 9.3% stake.
  • A broad neocloud sector derating — with rival CoreWeave (CRWV) also down roughly 28% — drove much of the decline, fueled by Meta's plans to commercialize surplus AI computing capacity.
  • Insider selling exceeding $140 million, a $20–25 billion 2026 capex forecast, and a DA Davidson downgrade from Buy to Neutral compounded selling pressure through mid-July.
  • The stock rebounded 18.78% on July 21 after Nvidia's 13G filing confirmed a 9.3% passive stake, joined by analyst upgrades from Freedom Capital and Northland Securities.
  • Despite the correction, Nebius maintains over $40 billion in contracted revenue backlog, Q1 revenue growth of 684% year-over-year, and strong backing from Nvidia, Microsoft (MSFT), and Meta Platforms (META).

Nebius Group (NBIS) Company Overview and Market Position

Nebius Group N.V., headquartered in Amsterdam, is a leading artificial intelligence cloud infrastructure provider — often referred to as a "neocloud" company. Spun out of the Russian internet conglomerate Yandex, Nebius designs and operates GPU-accelerated data centers purpose-built for AI training and inference workloads. Rather than building AI models itself, the company provides the high-performance computing infrastructure that enterprises and developers need to run demanding AI applications. This "picks and shovels" business model has attracted marquee customers including Microsoft and Meta Platforms, alongside a $2 billion strategic investment from Nvidia. With a contracted revenue backlog exceeding $40 billion and plans to build over five gigawatts of computing capacity by 2030, Nebius has positioned itself as one of the fastest-growing pure-play AI infrastructure companies on the public markets.

Nebius Group (NBIS) Stock Price Performance: Last 30 Days vs. Quarter

Over the past 30 days, NBIS shares dropped from a closing price of $283.61 on June 22, 2026 — near the stock's all-time high of $299.86 — to $216.92 on July 21, representing a decline of approximately 24%. The selloff was not linear; the stock experienced several sharp down days, including a nearly 14% plunge in a single session, before staging an 18.78% recovery on July 21 following the Nvidia stake disclosure and a wave of analyst upgrades.

The quarterly picture tells a more complex story. NBIS entered the quarter near its peak and has since surrendered roughly 40% from its June high. However, the stock remains up approximately 110% year-to-date, reflecting the extraordinary rally that preceded the recent correction. The broader uptrend that defined NBIS since late 2024 remains structurally intact, but the last 30 days have introduced significant volatility as investors reassess valuations across the entire neocloud sector.

What Drove NBIS Stock Price in the Last 30 Days

The primary catalyst for the 30-day decline was a sector-wide derating of neocloud and AI data center stocks. Sentiment shifted sharply in early July after reports that Meta Platforms intends to monetize its surplus AI computing resources by launching its own cloud services division. As one of the largest customers of neocloud providers — including a $27 billion infrastructure deal with Nebius itself — Meta's potential entry as a competitor rattled investors across the space. CoreWeave (CRWV) fell roughly 28% over the same period, confirming that the selloff was thematic rather than company-specific.

Compounding the pressure, Nebius management raised its 2026 capital expenditure forecast to between $20 billion and $25 billion, with most new capacity not generating substantial revenue until early 2027. Investors grew increasingly concerned about the timeline for return on invested capital. At the same time, SEC filings revealed that top executives — including the CEO, CTO, and Chief Infrastructure Officer — had collectively sold more than $140 million in shares over the preceding 90 days. While insider selling can occur for personal financial planning reasons, the magnitude and timing weighed on sentiment.

DA Davidson downgraded Nebius from Buy to Neutral in mid-July, citing valuation after the stock's extraordinary run rather than any deterioration in business fundamentals. This added to the negative momentum. The stock found a floor in the $170–$195 range before rebounding sharply on July 21, when Nvidia's Schedule 13G filing publicly confirmed a 9.3% passive ownership stake. Freedom Capital upgraded NBIS to Buy with a $200 price target, while Northland Securities raised its target to a Street-high $410, reinforcing that long-term demand for AI infrastructure remains robust.

What Drove NBIS Stock Performance Over the Last Quarter

The broader quarterly trend reflects a tug-of-war between extraordinary business momentum and mounting valuation discipline among growth-stock investors. Nebius reported first-quarter 2026 revenue of $399 million, representing 684% year-over-year growth and beating consensus estimates. Adjusted EPS of $0.23 crushed expectations for a loss of $0.81 per share. Management reiterated full-year revenue guidance of $3 billion to $3.4 billion and raised contracted power guidance to over four gigawatts by year-end.

Strategic milestones also accumulated: the company broke ground on its first U.S. gigawatt-scale AI factory, acquired AI software firms Tavily, Eigen AI, and Clarifai, and signed a computing contract worth more than $1 billion with Reflection AI. Nvidia's $2 billion investment, announced in March and formalized through the July 13G filing, provided a powerful endorsement. Yet these achievements were partially overshadowed by the Meta overhang, massive capex requirements, insider selling, and a market rotation away from high-multiple growth names toward more defensive positions. The result was a quarter defined by a sharp rally followed by an equally sharp correction.

NBIS Stock Forecast Drivers: What Investors Should Watch Next

Nebius is scheduled to report second-quarter 2026 earnings on July 29, and the results will be critical in validating whether the company's revenue trajectory and margin profile justify its premium valuation. Investors should also monitor any updates to the $20–25 billion capex plan, progress on the asset-light partnership model, and further disclosures around customer concentration. The evolving competitive landscape — particularly Meta's cloud ambitions and hyperscaler in-sourcing trends — will remain a central risk. On the positive side, additional analyst upgrades, institutional accumulation, and the eventual exercise of Nvidia's warrants in September 2026 could act as catalysts. With a consensus analyst price target of approximately $253, representing roughly 17% upside from current levels, the market's verdict on July 29 will likely set the tone for NBIS shares through the remainder of the year. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Exploring Tickeron AI Trading Bots for Market Navigation

In volatile market environments like the one currently facing neocloud stocks, I find automated strategies helpful for navigating rapid sentiment shifts. Tickeron's Trending AI Robots page showcases a curated selection of the platform's top-performing AI-powered trading bots. While Tickeron offers hundreds of bots trading thousands of tickers across equities, ETFs, and forex, only those demonstrating the strongest recent performance and highest relevance appear in this featured section. Each bot employs distinct strategies — ranging from swing trading and trend following to mean reversion and breakout patterns — across different timeframes and market conditions. For traders seeking data-driven decision-making tools, exploring the Trending AI Robots page can provide valuable insight into which algorithmic approaches are currently resonating with real-time market dynamics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NBIS

NBIS in +18.55% Uptrend, rising for three consecutive days on August 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NBIS advanced for three days, in of 138 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NBIS's RSI Oscillator exited the oversold zone, of 11 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NBIS just turned positive on August 03, 2026. Looking at past instances where NBIS's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

NBIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on August 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NBIS as a result. In of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NBIS moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NBIS crossed bearishly below the 50-day moving average on July 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBIS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NBIS entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NBIS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.658) is normal, around the industry mean (5.731). NBIS has a moderately high P/E Ratio (73.313) as compared to the industry average of (29.187). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (32.393). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (57.471) is also within normal values, averaging (70.644).

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Spotify Technology SA (NYSE:SPOT), Nebius Group N.V. (NASDAQ:NBIS), Baidu (NASDAQ:BIDU), Tencent Music Entertainment Group (NYSE:TME), Pinterest (NYSE:PINS), Snap (NYSE:SNAP), Bilibili (NASDAQ:BILI).

Industry description

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

Market Cap

The average market capitalization across the Internet Software/Services Industry is 146.87B. The market cap for tickers in the group ranges from 2.69K to 4.37T. GOOGL holds the highest valuation in this group at 4.37T. The lowest valued company is STBXF at 2.69K.

High and low price notable news

The average weekly price growth across all stocks in the Internet Software/Services Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -5%. AREN experienced the highest price growth at 35%, while ONFO experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Internet Software/Services Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 73
Price Growth Rating: 61
SMR Rating: 79
Profit Risk Rating: 94
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
NBIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an investment holding company with interest in providing internet search engine services

Industry InternetSoftwareServices

Profile
Details
Industry
Internet Software Or Services
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.